S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
NASDAQ:HARP

Harpoon Therapeutics Short Interest Ratio and Short Volume

$19.29
+0.98 (+5.35 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.80
Now: $19.29
$19.50
50-Day Range
$17.85
MA: $20.53
$24.16
52-Week Range
$10.27
Now: $19.29
$25.24
Volume196,949 shs
Average Volume321,547 shs
Market Capitalization$489.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.87

Short Interest

Harpoon Therapeutics (NASDAQ:HARP) Short Interest Data

Current Short Volume719,700 shares
Previous Short Volume751,500 shares
Change Vs. Previous Month:-4.23%
Dollar Volume Sold Short$15.32 million
Short Interest Ratio / Days to Cover3.0
Last Record DateJanuary, 29 2021
Outstanding Shares24,370,000 shares
Float Size20,410,000 shares
Short Percent of Float3.53%
Today's Trading Volume196,949 shares
Average Trading Volume321,547 shares
Today's Volume Vs. Average-38.75%

Short Interest Over Time


Harpoon Therapeutics (NASDAQ:HARP) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/2021719,700 shares $15.32 million -4.2%3.5%2.9 $21.29
1/15/2021751,500 shares $14.02 million -11.3%3.9%3.3 $18.66
12/31/2020688,800 shares $14.91 million -13.2%4.6%4.7 $21.64
12/15/2020688,800 shares $13.17 million -13.2%4.6%4.7 $19.12
11/30/2020793,700 shares $11.81 million -1.4%5.3%5.5 $14.88
11/15/2020804,900 shares $12.01 million -6.2%5.4%4.8 $14.92
10/30/2020858,500 shares $13.39 million -0.1%5.7%2.8 $15.60
10/15/2020859,500 shares $13.24 million -2.4%5.8%2.6 $15.41
9/30/2020880,600 shares $14.77 million +6.5%5.9%2.6 $16.77
9/15/2020826,600 shares $12.77 million +27.3%5.6%2.4 $15.45
8/31/2020649,200 shares $9.71 million -0.5%4.4%2 $14.95
8/14/2020652,700 shares $8.94 million +1.3%4.4%2 $13.70
7/31/2020644,300 shares $8.02 million +23.2%4.4%3.1 $12.45
7/15/2020522,900 shares $5.76 million +17.2%3.6%2.8 $11.01
6/30/2020446,300 shares $5.75 million +102.1%3.1%2.6 $12.89
6/15/2020220,800 shares $3.83 million +4.5%1.5%1.5 $17.33
5/29/2020211,300 shares $3.74 million -33.3%1.5%1.4 $17.70
5/15/2020316,700 shares $6.89 million +29.1%2.2%2.9 $21.76
4/30/2020245,300 shares $5.32 million -21.9%1.7%3 $21.69
4/15/2020314,100 shares $4.41 million +0.7%2.2%3.2 $14.03
3/31/2020311,900 shares $3.88 million +7.9%2.2%2.9 $12.43
3/13/2020289,000 shares $3.31 million +12.9%2.1%4.4 $11.47
2/28/2020256,100 shares $2.86 million +1.8%1.9%1.9 $11.15
2/14/2020251,600 shares $3.56 million -28.3%1.8%1.8 $14.16
1/31/2020351,000 shares $5.17 million +6.7%2.6%2.5 $14.73

Harpoon Therapeutics (NASDAQ:HARP) Short Interest FAQ

speech bubbles
speech bubbles











What is Harpoon Therapeutics' current short interest?

Short interest is the volume of Harpoon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 29th, traders have sold 719,700 shares of HARP short. 3.53% of Harpoon Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for Harpoon Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Harpoon Therapeutics currently has a short interest ratio of 3.0.

What is a good short interest percentage for Harpoon Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.53% of Harpoon Therapeutics' floating shares are currently sold short.

Is Harpoon Therapeutics' short interest increasing or decreasing?

Harpoon Therapeutics saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 719,700 shares, a decrease of 4.2% from the previous total of 751,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Harpoon Therapeutics' float size?

Harpoon Therapeutics currently has issued a total of 25,380,000 shares. Some of Harpoon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harpoon Therapeutics currently has a public float of 20,410,000 shares.

How does Harpoon Therapeutics' short interest compare to its competitors?

3.53% of Harpoon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Harpoon Therapeutics: BioCryst Pharmaceuticals, Inc. (0.00%), C4 Therapeutics, Inc. (4.43%), Scholar Rock Holding Co. (5.82%), Translate Bio, Inc. (0.00%), Sangamo Therapeutics, Inc. (0.00%), Replimune Group, Inc. (9.40%), Forma Therapeutics Holdings, Inc. (9.89%), Krystal Biotech, Inc. (8.12%), Immunovant, Inc. (6.22%), and REGENXBIO Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Harpoon Therapeutics stock?

Short selling HARP is an investing strategy that aims to generate trading profit from Harpoon Therapeutics as its price is falling. Harpoon Therapeutics' stock is trading up $0.98 today. To short Harpoon Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Harpoon Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Harpoon Therapeutics?

A short squeeze for Harpoon Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HARP, which in turn drives the price of the stock up even further.

How often is Harpoon Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HARP, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.